Gameday Men's Health Fresno ED and TRT Clinic
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- Shockwave Therapy
- IV Therapy
Fresno, CA
Fresno has multiple clinics advertising shockwave therapy, spanning orthopedic, podiatric, men's health, and aesthetic applications. California has the largest shockwave market in the country, with dense GAINSWave licensee networks and a mature aesthetic shockwave (cellulite, skin tightening) segment. Fresno providers typically run focused shockwave for FDA cleared orthopedic indications like plantar fasciitis, lateral epicondylitis tennis elbow, and chronic tendinopathy, and radial or low intensity shockwave (LI-ESWT, often branded as GAINSWave) off label for erectile dysfunction in 6 session protocols. Kidney stone lithotripsy is a separate FDA cleared category usually performed in hospital settings. Local pricing in Fresno sits in the affordable range, with a standard 6 session ED protocol commonly quoted at 2,000 to 4,000 dollars, while single session orthopedic shockwave runs 250 to 500. Device matters: verify the clinic uses an FDA cleared unit like Storz, Chattanooga, or BTL rather than a low end imported device. Evidence for orthopedic shockwave is Strong for plantar fasciitis and tennis elbow, while LI-ESWT for ED remains Emerging, with several randomized trials showing benefit but inconsistent protocols. A reputable Fresno clinic frames this evidence honestly and matches provider specialty to the indication.
Regulatory context
The FDA has granted 510(k) clearance to specific extracorporeal shockwave devices for chronic plantar fasciitis and lateral epicondylitis, and shockwave lithotripsy is approved for kidney stone fragmentation under 21 CFR 876. Low-intensity extracorporeal shockwave therapy (LI-ESWT) is not FDA-approved for erectile dysfunction as of 2026, and no shockwave device is cleared for knee osteoarthritis, Peyronie's disease, cellulite, or sexual wellness indications. Off-label clinical use of cleared devices is permitted, but manufacturers and clinics cannot promote the device for uses outside its cleared indications without triggering FDA and FTC scrutiny.
The Medical Board of California and the California Attorney General have pursued clinics for unsubstantiated claims about shockwave therapy, particularly in men's health, anti-aging, and aesthetic settings. California's false advertising and unfair competition statutes (B&P 17200, 17500) are used aggressively against clinics implying FDA approval for off-label uses such as ED or Peyronie's. The state also enforces corporate practice of medicine restrictions, meaning non-physician-owned shockwave clinics must be structured through a professional corporation or management services organization. Enforcement risk is meaningfully higher for clinics using the phrase "FDA-approved for ED."